Merck stops a study of what it hoped would be a new way to treat high cholesterol. ... Merck Gives Up On Drug After FDA Ruling TRENTON, N.J. -- The drugmaker said Wednesday an advisory committee recommended ending the study of cholesterol drug MK-0524A, two months after...
[read full story]